Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Donate Visit Malaria Consortium U.S.
  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us
  • Home
  • »
  • Resources
  • »
  • Publications
  • »
  • Reducing malaria morbidity in infants through intermittent preventive treatment in Nigeria

Share this page

Resources

Latest

Publications

Publication Date:
31/03/2021

Type:
Project brief
Publication

Reducing malaria morbidity in infants through intermittent preventive treatment in Nigeria

Publication Date:
31/03/2021
Type:
Project brief

To reduce malaria morbidity and mortality in infants, the World Health Organization (WHO) recommends intermittent preventive treatment in infants (IPTi) with sulfadoxine-pyrimethamine in areas with moderate to high malaria transmission. However, a decade after WHO’s recommendation, only one country has adopted the strategy as national policy, and various barriers to IPTi policy uptake remain. This study will assess IPTi’s clinical effectiveness and operational feasibility in Nigeria. It aims to generate the necessary evidence to support the intervention’s uptake in the national health policy. 

Click here to download View on projects database

Country: Nigeria

Keywords: Capacity development | Public health communications | Research | Child and maternal health | Policy development | Use of evidence | Malaria | Maternal, neonatal and child health | Preventive treatments | SDG3

 

 

« Back to Publications

Sign up for our publications newsletter here:

Sign up for our newsletters here:

  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us

Language Options: English | Français

© 2022 Malaria Consortium | Charity No. 1099776 | Company No. 4785712 | Privacy notice | Modern Slavery Statement | United Nations Global Compact